chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Limb discomfort, Magnetic resonance imaging head, Magnetic resonance imaging spinal abnormal, Micturition urgency
Clinical narrative: Four days after vaccine was given, patient experienced arm heaviness, gait instability, right hand numbness, and leg nubness from hip to feet. Patient presented to local hospital ER where provider evaluated and determined nothing was wrong. The condition got worse, legs began to shake, patient then presented to a larger hospital ER for a neurological evaluation. Patient was admitted to the hospital and worked up for stroke symptoms as well as trans-ischmic attack, which were negative. Numbness persisted and MRI with contrast of brain and cervical spine was done. It was noted that there were 3 lesions in the cervical spine area that were likely the cause of the patients symptoms. A spinal tap was deferred until wash out period of antiplatelet therapy was done. Patient received 3 x 1gm Methylprednisolone in the hosptial and was discharged on day 4 after presetation to hospital with diagnosis of acute transverse myelitis. Patient received spinal tap 7 days later with additonial blood testing. Significant findings from spinal tap included myelin binding protein and was negative for oligioclonal bands. No infection was noted. Patient followed up with neurologist on day 29 of symptom onset after discharge. Patient continues to have symptoms of numbness and burnign in legs and feet, numbness in torso region and right hand fingertips. She has bowel and bladder urgency but not incontinence. The neurologist determined this was an isolated case of acute transverse myelitis as all other potential neruological conditions were ruled out. Further MRI of brain and cervical spine recommended in 5 months to determine resolution of leisons or worsening of condition. Patient received a second course of oral prednisone taper for ongoing symptoms.
Age: 45.0
Sex: F
Vaccine: FLU4
Symptoms: Myelitis transverse, Neurological examination normal, Scan with contrast abnormal, Spinal cord disorder, Tremor
Clinical narrative: Four days after vaccine was given, patient experienced arm heaviness, gait instability, right hand numbness, and leg nubness from hip to feet. Patient presented to local hospital ER where provider evaluated and determined nothing was wrong. The condition got worse, legs began to shake, patient then presented to a larger hospital ER for a neurological evaluation. Patient was admitted to the hospital and worked up for stroke symptoms as well as trans-ischmic attack, which were negative. Numbness persisted and MRI with contrast of brain and cervical spine was done. It was noted that there were 3 lesions in the cervical spine area that were likely the cause of the patients symptoms. A spinal tap was deferred until wash out period of antiplatelet therapy was done. Patient received 3 x 1gm Methylprednisolone in the hosptial and was discharged on day 4 after presetation to hospital with diagnosis of acute transverse myelitis. Patient received spinal tap 7 days later with additonial blood testing. Significant findings from spinal tap included myelin binding protein and was negative for oligioclonal bands. No infection was noted. Patient followed up with neurologist on day 29 of symptom onset after discharge. Patient continues to have symptoms of numbness and burnign in legs and feet, numbness in torso region and right hand fingertips. She has bowel and bladder urgency but not incontinence. The neurologist determined this was an isolated case of acute transverse myelitis as all other potential neruological conditions were ruled out. Further MRI of brain and cervical spine recommended in 5 months to determine resolution of leisons or worsening of condition. Patient received a second course of oral prednisone taper for ongoing symptoms.
Sex: U
Vaccine: UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: Temperature excursions noted starting 1/20/.2023.  Revaccinating approximately 850 people following manufacturer guidelines.  No adverse events have been reported by any patients.  These excursions were self-reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pyrexia, Vomiting
Clinical narrative: patient called today to say she had fever, vomitting, and dizziness after receiving vaccine; states still having dizziness today
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: PATIENT WAS GIVEN THE WRONG MODERNA VACCINE.  SHE SHOULD HAVE RECEIVED THE 6M-11YR 0.25ML ,BUT WAS GIVEN 12YR AND OLDER 0.5ML
Age: 40.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Crying, Dysmenorrhoea, Heavy menstrual bleeding, Menstruation irregular, Mobility decreased
Clinical narrative: When my monthly period arrived (slightly earlier than usual), my cramps were incredibly painful and my period was unusually heavy. This has happened for a cycle or two after every COVID vaccine I have received. The cramps are so bad that I stay in bed and cry, heat compresses don't help, pain relievers don't help. They last for 2 full days.
Age: 40.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Muscle spasms
Clinical narrative: When my monthly period arrived (slightly earlier than usual), my cramps were incredibly painful and my period was unusually heavy. This has happened for a cycle or two after every COVID vaccine I have received. The cramps are so bad that I stay in bed and cry, heat compresses don't help, pain relievers don't help. They last for 2 full days.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Vial was mixed with the merck diluent intended for varicella/mmr/mmrv. Administrator mixed it, drew up .5mL and administered that instead of the correct method of defrosting and administering just the contents of the vial.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, COVID-19, Chest pain, Haemoglobin decreased, Intensive care
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/31/2023 Discharge Date: Sep 5, 2023 Discharge Disposition:  home health care svc DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Septic shock [A41.9, R65.21] COVID-19 [U07.1]   HOSPITAL COURSE: 78 years old woman presented with URI symptoms found to have COVID positive. She also had chest pain on admission with troponin 17 -> 17 -> 28. Discussed with on-call cardiologist, who recommended an echocardiogram on Tuesday. He also recommended daily EKG for her along with EKG if she develops chest pain.    ID was consulted with recommendations for IV remdesivir for 3 days that she completed.  She required vasopressor support with levophed which was weaned off gradually. She was treated with IV vanco/cefepime/flagyl with discontinuation of IV vancomycin with negative MRSA swab.   Medical intensive care unit had been consulted while the patient was in the intensive care unit with  recommendations for 5-7 days of empiric antibiotics.   Of note, the patient had developed anemia with transfusion of 1 unit of pRBC in the setting of her history of known coronary artery disease with some earlier complaints of chest pain hemoglobin had gone down to as low as  6.9 with a baseline thought to be closer to 10. Of note, she has had similar episodes in the past, last noted in March 2022.  Then, she had a hemoglobin of 6 and presented to the ER.  She was transfused 2 units at that time and was advised to be admitted the hospital for further evaluation but she declined this.  Since then, she is had no clinical signs of GI blood loss and her hemoglobin has overall remained stable.  Her hemoglobin did improve after transfusion and went up to 8.5.  There was no clinical signs of GI blood loss.  Discussion was had with the patient in regards to further workup for this but she stated that she would like to follow up with her primary care provider.  Patient was allowed to resume her aspirin therapy on discharge; Clopidogrel was held.  Reviewing the patient's outpatient records, during a previous admission she had been diagnosed with a TIA and was recommended to be on aspirin and Plavix for 1 month, followed by aspirin monotherapy thereafter.  Apparently, she is not been on monotherapy but has been taking clopidogrel and aspirin and she again was advised to remain on just aspirin.   Patient was thought to be medically stable for discharge home on 09/05.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell transfusion, Respiratory symptom, SARS-CoV-2 test positive, Septic shock, Staphylococcus test negative
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/31/2023 Discharge Date: Sep 5, 2023 Discharge Disposition:  home health care svc DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Septic shock [A41.9, R65.21] COVID-19 [U07.1]   HOSPITAL COURSE: 78 years old woman presented with URI symptoms found to have COVID positive. She also had chest pain on admission with troponin 17 -> 17 -> 28. Discussed with on-call cardiologist, who recommended an echocardiogram on Tuesday. He also recommended daily EKG for her along with EKG if she develops chest pain.    ID was consulted with recommendations for IV remdesivir for 3 days that she completed.  She required vasopressor support with levophed which was weaned off gradually. She was treated with IV vanco/cefepime/flagyl with discontinuation of IV vancomycin with negative MRSA swab.   Medical intensive care unit had been consulted while the patient was in the intensive care unit with  recommendations for 5-7 days of empiric antibiotics.   Of note, the patient had developed anemia with transfusion of 1 unit of pRBC in the setting of her history of known coronary artery disease with some earlier complaints of chest pain hemoglobin had gone down to as low as  6.9 with a baseline thought to be closer to 10. Of note, she has had similar episodes in the past, last noted in March 2022.  Then, she had a hemoglobin of 6 and presented to the ER.  She was transfused 2 units at that time and was advised to be admitted the hospital for further evaluation but she declined this.  Since then, she is had no clinical signs of GI blood loss and her hemoglobin has overall remained stable.  Her hemoglobin did improve after transfusion and went up to 8.5.  There was no clinical signs of GI blood loss.  Discussion was had with the patient in regards to further workup for this but she stated that she would like to follow up with her primary care provider.  Patient was allowed to resume her aspirin therapy on discharge; Clopidogrel was held.  Reviewing the patient's outpatient records, during a previous admission she had been diagnosed with a TIA and was recommended to be on aspirin and Plavix for 1 month, followed by aspirin monotherapy thereafter.  Apparently, she is not been on monotherapy but has been taking clopidogrel and aspirin and she again was advised to remain on just aspirin.   Patient was thought to be medically stable for discharge home on 09/05.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/31/2023 Discharge Date: Sep 5, 2023 Discharge Disposition:  home health care svc DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Septic shock [A41.9, R65.21] COVID-19 [U07.1]   HOSPITAL COURSE: 78 years old woman presented with URI symptoms found to have COVID positive. She also had chest pain on admission with troponin 17 -> 17 -> 28. Discussed with on-call cardiologist, who recommended an echocardiogram on Tuesday. He also recommended daily EKG for her along with EKG if she develops chest pain.    ID was consulted with recommendations for IV remdesivir for 3 days that she completed.  She required vasopressor support with levophed which was weaned off gradually. She was treated with IV vanco/cefepime/flagyl with discontinuation of IV vancomycin with negative MRSA swab.   Medical intensive care unit had been consulted while the patient was in the intensive care unit with  recommendations for 5-7 days of empiric antibiotics.   Of note, the patient had developed anemia with transfusion of 1 unit of pRBC in the setting of her history of known coronary artery disease with some earlier complaints of chest pain hemoglobin had gone down to as low as  6.9 with a baseline thought to be closer to 10. Of note, she has had similar episodes in the past, last noted in March 2022.  Then, she had a hemoglobin of 6 and presented to the ER.  She was transfused 2 units at that time and was advised to be admitted the hospital for further evaluation but she declined this.  Since then, she is had no clinical signs of GI blood loss and her hemoglobin has overall remained stable.  Her hemoglobin did improve after transfusion and went up to 8.5.  There was no clinical signs of GI blood loss.  Discussion was had with the patient in regards to further workup for this but she stated that she would like to follow up with her primary care provider.  Patient was allowed to resume her aspirin therapy on discharge; Clopidogrel was held.  Reviewing the patient's outpatient records, during a previous admission she had been diagnosed with a TIA and was recommended to be on aspirin and Plavix for 1 month, followed by aspirin monotherapy thereafter.  Apparently, she is not been on monotherapy but has been taking clopidogrel and aspirin and she again was advised to remain on just aspirin.   Patient was thought to be medically stable for discharge home on 09/05.
Age: 61.0
Sex: F
Vaccine: FLU4, RSV
Symptoms: Contusion, Erythema, Impaired work ability, Injected limb mobility decreased, Pain in extremity
Clinical narrative: After receiving Arexvy patient reported extreme pain in left arm, as well as redness and bruising. Patient says pain was so bad she could not lift her arm and had to call out of work the next day.
Age: 65.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Acute kidney injury, Alcohol withdrawal syndrome, Anxiety, COVID-19, COVID-19 pneumonia
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: PA-C Admission Date: 8/31/2023 Discharge Date: 9/6/2023      DETAILS OF HOSPITAL STAY:   Clinical Narrative:   The patient is a 66-year-old gentleman with a polysubstance use disorder who presented with anasarca and required diuresis.  He suffered some degree of acute kidney injury which required adjustment in his diuretic dosing.  He was noted to be in alcohol withdrawal and was on the Institute protocol.  Many of his symptoms seemed to be more anxiety related and he was transitioned from the Institute to the objective-measure only approach.  Psychiatry was also consulted.  A number of medication changes were made with respect to his psychotropics.  It is encouraged that he seek outpatient psychiatry services.  It was felt that subacute rehab would be most advantageous to him.  Given his COVID status and treatment for COVID-pneumonia, the rehab locations available to him were not acceptable to him and he continued to decline them.  After a period of time he did improve sufficiently to be discharged home though he continued to decline subacute rehab through the day of discharge.  He is felt to be at extremely high risk of readmission given his multiple complex comorbidities, polysubstance use disorder, social determinants of health, and his refused subacute rehab placement.
Age: 65.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Condition aggravated, Diuretic therapy, Generalised oedema
Clinical narrative: BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: PA-C Admission Date: 8/31/2023 Discharge Date: 9/6/2023      DETAILS OF HOSPITAL STAY:   Clinical Narrative:   The patient is a 66-year-old gentleman with a polysubstance use disorder who presented with anasarca and required diuresis.  He suffered some degree of acute kidney injury which required adjustment in his diuretic dosing.  He was noted to be in alcohol withdrawal and was on the Institute protocol.  Many of his symptoms seemed to be more anxiety related and he was transitioned from the Institute to the objective-measure only approach.  Psychiatry was also consulted.  A number of medication changes were made with respect to his psychotropics.  It is encouraged that he seek outpatient psychiatry services.  It was felt that subacute rehab would be most advantageous to him.  Given his COVID status and treatment for COVID-pneumonia, the rehab locations available to him were not acceptable to him and he continued to decline them.  After a period of time he did improve sufficiently to be discharged home though he continued to decline subacute rehab through the day of discharge.  He is felt to be at extremely high risk of readmission given his multiple complex comorbidities, polysubstance use disorder, social determinants of health, and his refused subacute rehab placement.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Pneumonia, Pyrexia
Clinical narrative: SOB, fever with chills, dyspnea, tachycardia,  PNA, cough
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: SOB, fever with chills, dyspnea, tachycardia,  PNA, cough
Age: 1.58
Sex: M
Vaccine: COVID19
Symptoms: Vaccine positive rechallenge
Clinical narrative: Was prepared incorrectly- mixed with the sterile diluent intended for merck varicella/mmr/mmrv vaccines, and then .5mL of the solution was administered.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Immunisation reaction, Rash, Rash papular, Rash pruritic
Clinical narrative: Pt reported red raised itchy rash that covered his body.   FNP said he is having an allergic reaction to the covid vaccine. FNP gave an order for Prednisone 40mg QD x5days, then 20mg QD x5days, then 10mg QD x5days, then 5mg QD x5days then stop and Atarax 10mg Q4hrs prn.
Age: 12.0
Sex: M
Vaccine: MENB
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Medication given early for age group No Symptoms for patient Reeducation with Physican and Resident staff
Age: 62.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: 11/12/2023- pain, itching , swelling, redness. soreness and warmth at injection site.  Continues today.
Age: 66.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site pruritus, Injection site scab
Clinical narrative: I have a half golf ball sized lump in my arm at the injection site since September 26th and its November 13th. Its tender and feverish still.  It is also kinda scabbed over because it is itchy. It is slightly red still too.
Age: 66.0
Sex: F
Vaccine: RSV
Symptoms: Injection site warmth
Clinical narrative: I have a half golf ball sized lump in my arm at the injection site since September 26th and its November 13th. Its tender and feverish still.  It is also kinda scabbed over because it is itchy. It is slightly red still too.
Age: 0.08
Sex: F
Vaccine: RV1
Symptoms: Anuria, Barium enema, Haematochezia, Infant irritability, Intussusception
Clinical narrative: Onset of symptoms on 11/6/23 at approximately 2200: not wanting to nurse, irritable, not making wet diapers in over 4 hours, one bloody stool, appeared to be in pain. Advised to go to the ER.  Went to ER.  Diagnosed with Intussusception and transferred to another hospital.  IV hydration and non-surgical reduction attempted with barium enema, but unsuccessful.   Surgical reduction with removal of right lower colon and part of the small intestines.
Age: 0.08
Sex: F
Vaccine: RV1
Symptoms: Large intestinal obstruction reduction, Pain, Poor feeding infant, Procedural failure, Small intestinal intussusception reduction
Clinical narrative: Onset of symptoms on 11/6/23 at approximately 2200: not wanting to nurse, irritable, not making wet diapers in over 4 hours, one bloody stool, appeared to be in pain. Advised to go to the ER.  Went to ER.  Diagnosed with Intussusception and transferred to another hospital.  IV hydration and non-surgical reduction attempted with barium enema, but unsuccessful.   Surgical reduction with removal of right lower colon and part of the small intestines.
Age: 0.08
Sex: F
Vaccine: RV1
Symptoms: X-ray
Clinical narrative: Onset of symptoms on 11/6/23 at approximately 2200: not wanting to nurse, irritable, not making wet diapers in over 4 hours, one bloody stool, appeared to be in pain. Advised to go to the ER.  Went to ER.  Diagnosed with Intussusception and transferred to another hospital.  IV hydration and non-surgical reduction attempted with barium enema, but unsuccessful.   Surgical reduction with removal of right lower colon and part of the small intestines.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Hypoxia, Loss of personal independence in daily activities, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Discharge Provider:  DO Primary Care Provider:  DO Admission Date: 8/31/2023 Discharge Date: 9/3/2023  DETAILS OF HOSPITAL STAY:   Clinical Narrative: 84 y/o F admitted for COVID 19+ infection with intractable symptoms with inability to care for herself.  She had hypoxia early on in the admission and has been on room air for several days.  She was given Remdesivir until 9/2.  She was seen by PT, OT and became stronger.  Patient was going to be discharged home on 9/2, but her transaminases increased.  Her Remdesivir was held the day of discharge, but her labs drawn prior to holding the medication were improved.  She didn't require any home oxygen.  She declined HHC services.     She will have repeat labs in 4 days and follow up with her PCP in a week.     Patient was admitted with sepsis on admission which resolved prior to discharge.     Thank you for the privilege of taking care of this nice lady.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Transaminases increased
Clinical narrative: Discharge Provider:  DO Primary Care Provider:  DO Admission Date: 8/31/2023 Discharge Date: 9/3/2023  DETAILS OF HOSPITAL STAY:   Clinical Narrative: 84 y/o F admitted for COVID 19+ infection with intractable symptoms with inability to care for herself.  She had hypoxia early on in the admission and has been on room air for several days.  She was given Remdesivir until 9/2.  She was seen by PT, OT and became stronger.  Patient was going to be discharged home on 9/2, but her transaminases increased.  Her Remdesivir was held the day of discharge, but her labs drawn prior to holding the medication were improved.  She didn't require any home oxygen.  She declined HHC services.     She will have repeat labs in 4 days and follow up with her PCP in a week.     Patient was admitted with sepsis on admission which resolved prior to discharge.     Thank you for the privilege of taking care of this nice lady.
Age: 28.0
Sex: F
Vaccine: TDAP
Symptoms: Wrong product administered
Clinical narrative: None, Pt should have received flu Vac.  Pt is fine and was notified.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered, No adverse event, Wrong patient received product
Clinical narrative: Patient was given his 0.25mL dose of Moderna COVID-19 and his mother's 0.5mL dose of Moderna COVID-19. LPN was aware of the error as soon as she went to enter lot numbers into the chart.  Notified provider, provider notified family.  Pt appeared well 15 minutes after vaccine was given.  Discussed things to watch out for including hives, increased respiratory rate, chest pain, shortness of breath and fever.  Encouraged ER visit with any of these symptoms.  Mom verbalized understanding.  Recommended waiting to complete influenza vaccine (1-2 weeks).
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Anxiety, Blood electrolytes, Bronchitis, COVID-19
Clinical narrative: Discharge Physician: MD Primary Care Physician: MD Date of Admission: 8/30/2023 Discharge Date: 8/31/2023 Room Number:  PRESENTING PROBLEM: Tachycardia [R00.0]   HOSPITAL COURSE: 27-year-old woman with a past medical history of Asperger's syndrome, PCOS who presented with a sore throat.  Associated symptoms include rhinorrhea, sinus pressure, sore throat, shortness of breath, cough with occasional sputum production, fatigue, subjective fever and chills.  She had initially presented to urgent care who found her to be tachycardic to 160, so she was sent to the emergency department.  Patient was given Decadron, Ativan, ibuprofen and placed on cardiac telemetry which revealed sinus tachycardia.  She was found to be COVID positive.  Chest x-ray was consistent with bronchitis without lobar pneumonia or other abnormality.  D-dimer was drawn and was elevated, so patient went for a CTA of the chest which was negative.  Patient was given Ativan for anxiety as well as a fluid bolus due to continued tachycardia.  This did bring her heart rates down, but she was admitted to be observed overnight to the hospitalist service.   While admitted, patient underwent echocardiogram which revealed an EF of 60% and no abnormalities.  She was given an additional bolus of IV fluids and heart rate decreased to the 110s.  Patient was discharged home with a prescription for Paxlovid.   Electrolytes were monitored and repleted throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac telemetry abnormal, Chest X-ray abnormal, Chills, Condition aggravated, Cough
Clinical narrative: Discharge Physician: MD Primary Care Physician: MD Date of Admission: 8/30/2023 Discharge Date: 8/31/2023 Room Number:  PRESENTING PROBLEM: Tachycardia [R00.0]   HOSPITAL COURSE: 27-year-old woman with a past medical history of Asperger's syndrome, PCOS who presented with a sore throat.  Associated symptoms include rhinorrhea, sinus pressure, sore throat, shortness of breath, cough with occasional sputum production, fatigue, subjective fever and chills.  She had initially presented to urgent care who found her to be tachycardic to 160, so she was sent to the emergency department.  Patient was given Decadron, Ativan, ibuprofen and placed on cardiac telemetry which revealed sinus tachycardia.  She was found to be COVID positive.  Chest x-ray was consistent with bronchitis without lobar pneumonia or other abnormality.  D-dimer was drawn and was elevated, so patient went for a CTA of the chest which was negative.  Patient was given Ativan for anxiety as well as a fluid bolus due to continued tachycardia.  This did bring her heart rates down, but she was admitted to be observed overnight to the hospitalist service.   While admitted, patient underwent echocardiogram which revealed an EF of 60% and no abnormalities.  She was given an additional bolus of IV fluids and heart rate decreased to the 110s.  Patient was discharged home with a prescription for Paxlovid.   Electrolytes were monitored and repleted throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram normal, Ejection fraction normal, Electrolyte substitution therapy, Fatigue
Clinical narrative: Discharge Physician: MD Primary Care Physician: MD Date of Admission: 8/30/2023 Discharge Date: 8/31/2023 Room Number:  PRESENTING PROBLEM: Tachycardia [R00.0]   HOSPITAL COURSE: 27-year-old woman with a past medical history of Asperger's syndrome, PCOS who presented with a sore throat.  Associated symptoms include rhinorrhea, sinus pressure, sore throat, shortness of breath, cough with occasional sputum production, fatigue, subjective fever and chills.  She had initially presented to urgent care who found her to be tachycardic to 160, so she was sent to the emergency department.  Patient was given Decadron, Ativan, ibuprofen and placed on cardiac telemetry which revealed sinus tachycardia.  She was found to be COVID positive.  Chest x-ray was consistent with bronchitis without lobar pneumonia or other abnormality.  D-dimer was drawn and was elevated, so patient went for a CTA of the chest which was negative.  Patient was given Ativan for anxiety as well as a fluid bolus due to continued tachycardia.  This did bring her heart rates down, but she was admitted to be observed overnight to the hospitalist service.   While admitted, patient underwent echocardiogram which revealed an EF of 60% and no abnormalities.  She was given an additional bolus of IV fluids and heart rate decreased to the 110s.  Patient was discharged home with a prescription for Paxlovid.   Electrolytes were monitored and repleted throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Heart rate increased, Oropharyngeal pain, Paranasal sinus discomfort, Productive cough
Clinical narrative: Discharge Physician: MD Primary Care Physician: MD Date of Admission: 8/30/2023 Discharge Date: 8/31/2023 Room Number:  PRESENTING PROBLEM: Tachycardia [R00.0]   HOSPITAL COURSE: 27-year-old woman with a past medical history of Asperger's syndrome, PCOS who presented with a sore throat.  Associated symptoms include rhinorrhea, sinus pressure, sore throat, shortness of breath, cough with occasional sputum production, fatigue, subjective fever and chills.  She had initially presented to urgent care who found her to be tachycardic to 160, so she was sent to the emergency department.  Patient was given Decadron, Ativan, ibuprofen and placed on cardiac telemetry which revealed sinus tachycardia.  She was found to be COVID positive.  Chest x-ray was consistent with bronchitis without lobar pneumonia or other abnormality.  D-dimer was drawn and was elevated, so patient went for a CTA of the chest which was negative.  Patient was given Ativan for anxiety as well as a fluid bolus due to continued tachycardia.  This did bring her heart rates down, but she was admitted to be observed overnight to the hospitalist service.   While admitted, patient underwent echocardiogram which revealed an EF of 60% and no abnormalities.  She was given an additional bolus of IV fluids and heart rate decreased to the 110s.  Patient was discharged home with a prescription for Paxlovid.   Electrolytes were monitored and repleted throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Sinus tachycardia, Tachycardia
Clinical narrative: Discharge Physician: MD Primary Care Physician: MD Date of Admission: 8/30/2023 Discharge Date: 8/31/2023 Room Number:  PRESENTING PROBLEM: Tachycardia [R00.0]   HOSPITAL COURSE: 27-year-old woman with a past medical history of Asperger's syndrome, PCOS who presented with a sore throat.  Associated symptoms include rhinorrhea, sinus pressure, sore throat, shortness of breath, cough with occasional sputum production, fatigue, subjective fever and chills.  She had initially presented to urgent care who found her to be tachycardic to 160, so she was sent to the emergency department.  Patient was given Decadron, Ativan, ibuprofen and placed on cardiac telemetry which revealed sinus tachycardia.  She was found to be COVID positive.  Chest x-ray was consistent with bronchitis without lobar pneumonia or other abnormality.  D-dimer was drawn and was elevated, so patient went for a CTA of the chest which was negative.  Patient was given Ativan for anxiety as well as a fluid bolus due to continued tachycardia.  This did bring her heart rates down, but she was admitted to be observed overnight to the hospitalist service.   While admitted, patient underwent echocardiogram which revealed an EF of 60% and no abnormalities.  She was given an additional bolus of IV fluids and heart rate decreased to the 110s.  Patient was discharged home with a prescription for Paxlovid.   Electrolytes were monitored and repleted throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Confusional state, Hyperkalaemia, Pain, Pyrexia
Clinical narrative: Hospitalized 9/20/22-9/23/22 Weakness, confusion, fever,  hyperkalemia, body ache, debility
Age: 56.0
Sex: M
Vaccine: RSV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient only 56 years of age. Not 60 or over. Medication administration error
Age: 76.0
Sex: M
Vaccine: UNK
Symptoms: Anxiety, Death, Dyspnoea, Endotracheal intubation, Haemothorax
Clinical narrative: Day after RSV vaccine woke up not feeling well and with a fever.  Took blood pressure at home which was low.  By evening experienced hard time taking deep breaths and went to ER 10/25 because worried it may get worse overnight.  Within a couple hours of walking into ER couldn't breath and had to be intubated and put on ventilator.  Doctors performed numerous tests over a period of 10 days and couldn't find out what was wrong and what triggered his lungs filling with blood and fluid.  Doctors said this wasn't a known reaction from RSV vaccine and therefore thought it wasn't related.  Had just gone to his doctor the Friday prior and received clean bill of health from primary care physician.  After 10 days on a Ventilator we had to make tough decision to let him go due to kidneys failing and couldn't get answers to what was wrong.  He passed away on Sunday November 5th at 1:53am at Hospital
Age: 76.0
Sex: M
Vaccine: UNK
Symptoms: Hypotension, Laboratory test normal, Malaise, Mechanical ventilation, Pulmonary oedema
Clinical narrative: Day after RSV vaccine woke up not feeling well and with a fever.  Took blood pressure at home which was low.  By evening experienced hard time taking deep breaths and went to ER 10/25 because worried it may get worse overnight.  Within a couple hours of walking into ER couldn't breath and had to be intubated and put on ventilator.  Doctors performed numerous tests over a period of 10 days and couldn't find out what was wrong and what triggered his lungs filling with blood and fluid.  Doctors said this wasn't a known reaction from RSV vaccine and therefore thought it wasn't related.  Had just gone to his doctor the Friday prior and received clean bill of health from primary care physician.  After 10 days on a Ventilator we had to make tough decision to let him go due to kidneys failing and couldn't get answers to what was wrong.  He passed away on Sunday November 5th at 1:53am at Hospital
Age: 76.0
Sex: M
Vaccine: UNK
Symptoms: Pyrexia, Renal failure
Clinical narrative: Day after RSV vaccine woke up not feeling well and with a fever.  Took blood pressure at home which was low.  By evening experienced hard time taking deep breaths and went to ER 10/25 because worried it may get worse overnight.  Within a couple hours of walking into ER couldn't breath and had to be intubated and put on ventilator.  Doctors performed numerous tests over a period of 10 days and couldn't find out what was wrong and what triggered his lungs filling with blood and fluid.  Doctors said this wasn't a known reaction from RSV vaccine and therefore thought it wasn't related.  Had just gone to his doctor the Friday prior and received clean bill of health from primary care physician.  After 10 days on a Ventilator we had to make tough decision to let him go due to kidneys failing and couldn't get answers to what was wrong.  He passed away on Sunday November 5th at 1:53am at Hospital
Age: 85.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Asthenia, Blood creatinine increased, COVID-19, Chest X-ray normal, Hypoxia
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/30/2023 Discharge Date: Sep 2, 2023 Discharge Disposition:  home health care svc  ?  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] COVID-19 [U07.1]   HOSPITAL COURSE: 86-year-old female with a past medical history significant for chronic kidney disease stage IIIB as well as known atrial tachycardia and hypertension who presents due to complaints of bilateral lower extremity weakness.   Patient also notably had some complaints suspected related to upper respiratory infection.  Patient is mildly hypoxic on admission with a 90% oxygen saturation on room air.  Labs were remarkable for a creatinine of 1.35.  COVID-19 testing came back positive.  Chest x-ray showed no acute infiltrate.  Patient was admitted to the hospital for further evaluation and treatment.   Patient was initially placed on supplemental oxygen with 2 liters/minute and started on oral Decadron.  Respiratory symptoms improve and patient was weaned off oxygen.  Patient was discharged to complete 6 days total of oral Decadron.  Patient was seen by PT and OT recommended home with home care.  Patient was subsequent discharged home in medically stable condition.
Age: 85.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Muscular weakness, Respiratory symptom, SARS-CoV-2 test positive, Upper respiratory tract infection
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/30/2023 Discharge Date: Sep 2, 2023 Discharge Disposition:  home health care svc  ?  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] COVID-19 [U07.1]   HOSPITAL COURSE: 86-year-old female with a past medical history significant for chronic kidney disease stage IIIB as well as known atrial tachycardia and hypertension who presents due to complaints of bilateral lower extremity weakness.   Patient also notably had some complaints suspected related to upper respiratory infection.  Patient is mildly hypoxic on admission with a 90% oxygen saturation on room air.  Labs were remarkable for a creatinine of 1.35.  COVID-19 testing came back positive.  Chest x-ray showed no acute infiltrate.  Patient was admitted to the hospital for further evaluation and treatment.   Patient was initially placed on supplemental oxygen with 2 liters/minute and started on oral Decadron.  Respiratory symptoms improve and patient was weaned off oxygen.  Patient was discharged to complete 6 days total of oral Decadron.  Patient was seen by PT and OT recommended home with home care.  Patient was subsequent discharged home in medically stable condition.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Patient received the vaccine on friday night and by the next morning a rash appeared that has now increased to the size of a baseball. Has taken Tylenol and used cold packs. Reporting on Monday and no resolution since. Rash appears a reddish-purple.
Age: 68.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Asthenia, Confusional state, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: Severe Muscle Aches, Fever, Weakness, Fatigue. I get kinda confused, lathargic, lack of breathing- lack of air in my lungs. Short of breath. Now I am like in a daze, and weak.
Age: 68.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Lethargy, Myalgia, Pyrexia
Clinical narrative: Severe Muscle Aches, Fever, Weakness, Fatigue. I get kinda confused, lathargic, lack of breathing- lack of air in my lungs. Short of breath. Now I am like in a daze, and weak.
Age: 91.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Chest X-ray normal, Cough, Dyspnoea, General physical health deterioration
Clinical narrative: Discharge Date: 09/07/2023 Discharge Provider: MD Primary Care Provider : MD   Admission Date: 8/29/2023 Admitting Diagnoses: COVID-19   Discharge Date: 9/7/2023  Details of Hospital Stay PRESENTING PROBLEM: COVID-19   HOSPITAL COURSE: Patient is a 92-year-old male with history of hypertension who presented from independent living with cough, fever and shortness of breath.  Vitals were stable in the emergency department.  Chest x-ray was unremarkable.  COVID-19 PCR was positive. He was admitted to the hospitalist team for further management.    Despite initial aggressive treatment, the patient was noted to become more lethargic and had difficulty managing his secretions. Given his decline, palliative care was consulted. Medications were started which have been successfully controlling his secretions.    Family members elected for comfort-focused care for patient. Patient was discharged back to Independent Living on 9/7 with hospice.
Age: 91.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Lethargy, Pyrexia, SARS-CoV-2 test positive, Secretion discharge
Clinical narrative: Discharge Date: 09/07/2023 Discharge Provider: MD Primary Care Provider : MD   Admission Date: 8/29/2023 Admitting Diagnoses: COVID-19   Discharge Date: 9/7/2023  Details of Hospital Stay PRESENTING PROBLEM: COVID-19   HOSPITAL COURSE: Patient is a 92-year-old male with history of hypertension who presented from independent living with cough, fever and shortness of breath.  Vitals were stable in the emergency department.  Chest x-ray was unremarkable.  COVID-19 PCR was positive. He was admitted to the hospitalist team for further management.    Despite initial aggressive treatment, the patient was noted to become more lethargic and had difficulty managing his secretions. Given his decline, palliative care was consulted. Medications were started which have been successfully controlling his secretions.    Family members elected for comfort-focused care for patient. Patient was discharged back to Independent Living on 9/7 with hospice.
Age: 79.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Acute respiratory failure, Asthenia, Atrioventricular block first degree, Balance disorder, Blood sodium decreased
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/29/2023 Discharge Date: 9/3/2023 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 80y/o male with a past medical history of BH. CAD, dilantin toxicity, epilepsy, dilantin toxicity, neuropathy, and sleep apnea who presented for increasing weakness.   Patients symptoms began 3 days prior to admission with increasing weakness and confusion, intermittent fevers, balance issues, and a fall  without LOC or head injury. Patient additionally began to develop a cough prior to presentation to the ED. With patient' s change from baseline, family called EMS to bring patient in. Upon evaluation, patient was put on 2L of oxygen on the way to the ED. Patient did not wear oxygen at baseline. In the Emergency Department, patient presented with a fever of 101.8, tachypnea, and SpO2 at 91% on 2L NC. Basic labs were ordered and revealed a mild normocytic anemia with hgb 13.2, elevated CRP of 24.1, and a mild hyponatremia 133 but were otherwise benign. 4-plex was completed and came back COVID positive. Patient was placed in respiratory precautions. EKG findings demonstrated increased PR interval from known first degree AV block, PACs, and T wave abnormality, but not significantly different from previous findings. CXR revealed mild pulmonary vascular congestion but no signs of pneumonia. D-dimer was slightly elevated at 660. Hospitalist team was contacted for further evaluation.    Upon admission patient was started on remdesivir and lasix. Patient was placed in seizure precautions with his history of having seizures 1-2 times weekly. PT/OT evaluation recommending SAR, but on day 2 of admission noting that pt is improving and could potentially progress to home. Pt had a controlled fall on the morning of 9/1/2023 where he misstepped from the practice stairs, and PT was able to lower him to the ground. He sustained no injuries. On reevaluation on day of dc felt safe for dc home with HHC physical therapy . Rec on dc 2 person assist with stairs and standby assist with other ambulation.  Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge
Age: 79.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: C-reactive protein increased, COVID-19, Chest X-ray abnormal, Confusional state, Cough
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/29/2023 Discharge Date: 9/3/2023 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 80y/o male with a past medical history of BH. CAD, dilantin toxicity, epilepsy, dilantin toxicity, neuropathy, and sleep apnea who presented for increasing weakness.   Patients symptoms began 3 days prior to admission with increasing weakness and confusion, intermittent fevers, balance issues, and a fall  without LOC or head injury. Patient additionally began to develop a cough prior to presentation to the ED. With patient' s change from baseline, family called EMS to bring patient in. Upon evaluation, patient was put on 2L of oxygen on the way to the ED. Patient did not wear oxygen at baseline. In the Emergency Department, patient presented with a fever of 101.8, tachypnea, and SpO2 at 91% on 2L NC. Basic labs were ordered and revealed a mild normocytic anemia with hgb 13.2, elevated CRP of 24.1, and a mild hyponatremia 133 but were otherwise benign. 4-plex was completed and came back COVID positive. Patient was placed in respiratory precautions. EKG findings demonstrated increased PR interval from known first degree AV block, PACs, and T wave abnormality, but not significantly different from previous findings. CXR revealed mild pulmonary vascular congestion but no signs of pneumonia. D-dimer was slightly elevated at 660. Hospitalist team was contacted for further evaluation.    Upon admission patient was started on remdesivir and lasix. Patient was placed in seizure precautions with his history of having seizures 1-2 times weekly. PT/OT evaluation recommending SAR, but on day 2 of admission noting that pt is improving and could potentially progress to home. Pt had a controlled fall on the morning of 9/1/2023 where he misstepped from the practice stairs, and PT was able to lower him to the ground. He sustained no injuries. On reevaluation on day of dc felt safe for dc home with HHC physical therapy . Rec on dc 2 person assist with stairs and standby assist with other ambulation.  Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge